Nalagenetics
News,Biotech / MedTech,Singapore
Singapore biotech firm Nalagenetics raises $12.6M Series A funding co-led by Intudo Ventures and Vulcan Capital
Nalagenetics announced Friday the closing of a $12.6 million Series A round of financing co-led by Intudo Ventures and Vulcan Capital. The round also saw participation from strategic investors, including Singapore-based Diagnostics Development Hub (DxD Hub) through the Agency for Science, Technology and Research’s (A*STAR) A*ccelerate Technologies Pte Ltd,…
March 25, 2022
VinFast remains in the red in Q2 despite higher revenue
September 5, 2025
Ant International’s Antom debuts agentic payment solution
September 5, 2025
VinFast remains in the red in Q2 despite higher revenue
September 5, 2025
Ant International’s Antom debuts agentic payment solution
September 5, 2025